Enjoy complimentary customisation on priority with our Enterprise License!
The Female Contraceptive Market is estimated to grow at a CAGR of 5.32% between 2022 and 2027. The size of the market is forecast to increase by USD 5,142.22 million. The growth of the market depends on several factors, including the increasing adoption of innovative marketing strategies, evolving consumer perspectives, and the availability of different methods of contraception.
This report extensively covers market segmentation by distribution channel (offline and online), product (female contraceptive devices and female contraceptive drugs), and geography (North America, Europe, APAC, South America, and the Middle East and Africa). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
To learn more about this report, Download Report Sample
The increasing adoption of innovative marketing strategies is notably driving the market growth, although factors such as non-uniformity in sex education in developed countries may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Female Contraceptive Market Driver
The global growth of the female contraceptive market is driven by the increasing adoption of innovative marketing strategies. Vendors are investing heavily in advertising and marketing, resulting in market growth. Leading contraceptive brands are spending more on marketing to maintain their market dominance. PR activities are being conducted to generate curiosity among women to try different female contraceptives like birth control pills.
In addition, marketing approaches include print advertisements and events, attracting women from various demographics and increasing demand for birth control pills. Extensive marketing efforts can popularize a vendor's range of products. Short-term video advertisements also raise awareness about female contraceptives and encourage users to discuss birth control with doctors, leading them to try different brands. Such initiatives boost sales of birth control pills and propel the market's growth.
Key Female Contraceptive Market Trend.
The increasing popularity of female condoms will fuel the global female contraceptive market growth. The market has been witnessing the rising popularity of female condoms in the past two years. In developed countries, the adoption of female condoms is increasing, which is creating a demand for such products. In the US, the government is distributing a large number of female condoms through beauty salons, convenience stores, and clinics under its DC program to curb the rising rates of HIV infections in the country. Also, trained officials communicate with women to know about their sexual health, which helps achieve higher acceptance rates for female condoms.
Moreover, the second-generation female condoms manufactured by FH2 (a brand of Veru) have reduced the cost of female condoms and made their pricing equivalent to that of male condoms. Female condoms are critically important, especially for high-risk sex workers who may face condom refusal. Also, they are an ideal alternative to contraceptive pills for women who prefer not to use hormonal methods to prevent pregnancy. Therefore, these factors are increasing the popularity of female condoms globally.
Key Female Contraceptive Market Challenge
Non-uniformity in sex education in developed countries is a major challenge to the global female contraceptive market growth. While developed countries such as the US consider themselves sexually liberated countries, non-uniformity in imparting sex education is affecting awareness of sex among teenagers, which is reducing the demand for female contraceptives. If teenagers are not educated properly about the various aspects of sex, the use of female contraceptives will be limited among them.
In the US, in several states, there is a focus on abstinence-only sex education, which is a form of sex education that promotes and teaches students not to have sex outside marriage or premarital sex. Furthermore, such education excludes the teaching of birth control measures and safe sex. This has increased teenage pregnancy rates. Therefore, unless proper and scientifically accurate sex education is imparted in schools, the adoption of products such as female condoms will be low, as teenagers will not be aware of the availability of such products. This could affect the growth of the global female contraceptive market during the forecast period.
Key Female Contraceptive Market Customer Landscape
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Female Contraceptive Market Customer Landscape
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abbvie- The company offers female contraceptives such as Liletta Intrauterine Contraceptive. Also, under this segment, the company conducts research and development, manufacturing, commercialization, and sale of innovative medicines and therapies to allocate resources and assess business performance on a global basis in order to achieve its established long-term strategic goals.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
A qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
The market share growth by the offline segment will be significant during the forecast period. This segment includes adult stores and vending machines. The segment will grow at a moderate rate due to the low presence of these stores near residential complexes and localities. However, with the growing real estate sector, these establishments are setting up bases close to family neighborhoods to sustain healthy revenue. This segment affects the sales of convenience stores, merchandisers, and drugstores to an extent.
Get a glance at the market contribution of various segments Request a PDF Sample
The offline segment showed a gradual increase in market share with USD 10,036.76 million in 2017 and will continued to grow by 2021. Vending machines also contribute significant revenue to the segment and the global market. Countries such as the US, the UK, France, Germany, China, and Japan have a large number of branded condom vending machines. Also, in many countries, governments, health organizations, and NGOs are installing vending machines that provide condoms at a low cost, which is expected to drive the growth of the segment during the forecast period.
This segment is expected to grow at a rapid pace during the forecast period. The sales of female contraceptives through online channels have been boosted by changes in shopping preferences. Presently, the majority of customers are relying on online research through websites, blogs, and social media to make purchase decisions. This trend is being driven by the widespread penetration and geographical reach of e-commerce giants like Amazon, Alibaba, and JD. The availability of a robust infrastructure for e-commerce services has also led to a surge in demand for the online distribution channel. The growth of this sector is expected to be fueled by increasing internet penetration and the growing usage of smartphones in the coming forecast period.
For more insights on the market share of various regions Request PDF Sample now!
North America is projected to contribute 38% of market growth by 2027. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The female contraceptive market in North America is growing due to high product penetration and availability. The availability of advanced female contraceptive products such as IUDs has driven the growth of the market in the region. As these devices are considered effective in preventing pregnancies and are cost-effective as they are generally used for longer periods of time, their demand is increasing in the region.
This report forecasts the contribution of all the segments to the growth of the market. In addition, we have included the COVID-19 impact and the recovery strategies for each segment. COVID-19 led to a surge in the demand for female contraceptives in North America. However, in the second half of 2020, the COVID-related restrictions were somewhat relaxed in various countries, which led to the resumption of business activities and essential services, including the availability of OTC contraceptives. The relaxation of such restrictions has encouraged people to go for health checkups and treatments, which is expected to drive the growth of the female contraceptive market in North America during the forecast period.
Technavio categorizes the global female contraceptive market as a part of the global personal products market within the global household and personal products market. The parent global personal products market covers products and companies engaged in research and development (R and D) and the production of personal and beauty care products, including cosmetics and perfumes. The scope of the global personal products market also includes personalized gifts, sleep masks, sex toys, hair wigs and extensions, and polarized sunglasses markets. Our research report has extensively covered external factors influencing the parent market growth during the forecast period.
The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. The market has been segmented by distribution channel, product, and region.
Female Contraceptive Market Scope |
|
Report Coverage |
Details |
Page number |
168 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.32% |
Market growth 2023-2027 |
USD 5,142.22 million |
Market structure |
Fragmented |
YoY growth (%) |
4.2 |
Regional analysis |
North America, Europe, APAC, South America, and the Middle East and Africa |
Performing market contribution |
North America at 38% |
Key countries |
US, Canada, China, Japan, and France |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
AbbVie Inc., Afaxys Pharma LLC, Agile Therapeutics Inc., Amgen Inc., Ansell Ltd., Bayer AG, CooperSurgical Inc., Cupid Ltd., Exeltis USA Inc., Johnson & Johnson, Mayer Laboratories Inc., Medisafe Distribution Inc., Merck & Co. Inc., Mylan NV, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Veru Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.